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Abstract: In this editorial, we will discuss one promising tool to encourage physical activity
participation in individuals with chronic disease: The use of wearable technology.
Keywords: chronic disease; wearable technology; self-monitoring; accuracy; physical activity

In this Special Issue on Exercise and Chronic Disease in IJERPH, contributions that examine the
role of physical activity (PA) on health in chronic disease were invited. While there continues to be
much-needed research published that characterizes the importance of PA in individuals with chronic
disease, there is still the question about how researchers and the healthcare team can work to increase
PA participation rates in the context of chronic disease. In this Editorial, we will discuss one promising
tool to encourage PA participation: The use of wearable technology.
Wearable technology is extremely popular and was named the #1 fitness trend in 2019 by the
American College of Sports Medicine’s Health and Fitness Journal [1]. Wearable technology for the
quantification of human movement typically includes devices worn on the wrist, chest, arm, hip,
or any other part of the body that can measure PA by movement, heart rate, or global positioning
system (GPS). One very common and increasingly popular choice of wearable technology is the fitness
watch. Fitness watches, by companies such as Apple, Fitbit, Garmin, Misfit, and Polar, include a
lot of capabilities. For example, most fitness watches have integrated accelerometers that quantify
movement in multiple directions, but upgraded fitness watches also employ heart-rate monitors,
altimeters, and global positioning systems (GPS) to better track daily activity and other indices of
health. Combined, this information can provide accurate and detailed information about daily PA.
PA is associated with many health benefits, and there is evidence for a dose-response relationship
between PA participation and improved cardiorespiratory, metabolic, musculoskeletal, and mental
health [2]. PA participation is also associated with a decreased burden of disease, such as colon
and breast cancers, diabetes, and osteoporosis among others [3,4]. Beyond disease prevention,
increased PA is independently associated with a decrease in all-cause mortality in adults [5]. Thus,
the evidence is strong that participation in PA not only improves health and prevents, treats, and/or
alleviates many chronic diseases, but it can also be used to increase longevity and quality of life.
Despite this, individuals with chronic disease often participate in low levels of PA; often, they do
not meet international guidelines for suggested amounts of PA, and compared to healthy controls,
chronic disease populations have worse PA engagement [6]. There remains a disconnect between
the research demonstrating the benefits of PA in individuals with chronic disease and the uptake of
PA behavior.
Wearable technologies are continuously improving, by integrating with smartphones and their
associated apps and platforms more seamlessly. They are also becoming more fashionable and,
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thus, desirable to wear. For example, Fitbit and Apple not only offer features such as integrated
GPS, heart-rate monitoring, sleep insights, and food-intake monitoring that sync with a smartphone,
these companies also offer fitness watches with interchangeable watch faces and watch bands.
Data highlighting the growing popularity of wearable technology are beginning to emerge; for example,
a representative sample of 1215 adults from Canada indicated that 38% of people have access to
a physical activity-tracking device [7]. In a sample of Finnish adolescents, 27% (1190/4413) of the
adolescences owned a smartwatch or a heart-rate monitor [8]. Even older adults report using technology
to monitor PA; in one survey of adults (≥50 years of age) in Switzerland, it was found that 20.5%
used mobile devices to keep track of PA levels [9]. Thus, wearable technology may be a tool to help
increase physical activity and improve health in persons with chronic diseases. In assessing the utility
of wearable technology (more specifically, fitness watches) in persons with chronic disease, we will
briefly examine the following questions: (1) Can a fitness watch help someone with a chronic disease
increase their physical activity? (2) How does a fitness watch help someone with a chronic disease
improve their physical activity? (3) What are some important considerations and what research needs
to be conducted to help us better understand the relationship between fitness watch use and chronic
disease management?
1. Can a Fitness Watch Help Someone with a Chronic Disease Increase Their Physical Activity?
In otherwise healthy populations, wearable technology has been demonstrated to increase daily PA
levels, and the ability of wearable technology to increase PA seems to vary based on individual factors
including lower baseline PA [10], meaning that a lower baseline PA is associated with an increased
benefit of using wearable technology to increase PA. Since the PA levels of chronic disease populations
are often reported as lower than that of healthy populations, there may be an opportunity to increase
PA using wearable technology to a greater degree than has been demonstrated in healthy populations.
Current research suggests that fitness watches can increase PA and could, theoretically, be used
in combination with other medical recommendations to improve health parameters in those with
chronic disease. For example, activity monitors (or fitness watches), in combination with other lifestyle
interventions, appear to be successful at increasing PA in obese men and women [11], depressed and
alcohol-dependent women [12], and breast cancer survivors [13]. In one study, authors examined the
ability of a fitness watch to increase moderate to vigorous PA in overweight/obese adults over six weeks,
while also examining if the addition of encouraging/reminder text messages (SMS) to a participant’s
cell phone would further influence PA. This study found that the use of the fitness watch increased
moderate to vigorous PA, but that the addition of the SMS messages did not impact PA participation
significantly beyond one week of follow-up [14]. Thus, fitness watches might independently be a
potent way to increase PA. Other pilot studies have demonstrated the feasibility of fitness watch use in
childhood cancer survivors [15,16] and pediatric juvenile idiopathic arthritis patients [17]. These few
studies demonstrate that increases in steps, total daily PA, and moderate/vigorous PA are possibly
facilitated by fitness watch use, but that fitness watches may need to be used in combination with
behavioral interventions that include some type of encouragement to increase PA and goal setting.
2. How Does a Fitness Watch Help Someone with a Chronic Disease Improve Their PA?
Fitness watches allow users to see their personal, real-time PA by having constant access to this
information on their wrists, and, therefore, employ self-monitoring of PA. Self-monitoring is common
in many lifestyle interventions that focus on increasing PA or changing nutrition and food intake.
Self-monitoring one’s food intake can have a very beneficial effect on healthier eating habits and has
been reported to improve success during weight-loss interventions [18]. Theoretically, the individual
can then make a purposeful decision to do more PA, e.g., go for a walk on their lunch break, because they
have a greater awareness about their daily activity.
Technology (fitness watches and activity trackers) work to increase the user’s awareness of their
actual daily PA, and if they are motivated to change their behavior (such as by direction via their
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healthcare team), the individual can increase their activity to achieve predetermined PA goals. By using
self-monitoring techniques that provide awareness of PA, use of a fitness watch can help someone
improve their PA. This motivation to increase PA with wearable technology has been demonstrated
in individuals with chronic disease as well; one recent study conducted a qualitative analysis in 29
participants with chronic disease, and found that participants thought the use of wearable technology
(in this case, an activity tracker) motivated them to be more active [19].
Fitness watches may help someone improve PA based on many different individual factors. To this
end, Ellingson et al. [10] demonstrated in healthy individuals that activity trackers can have beneficial
effects on PA, but these results varied based on the individual. For example, individuals with low
initial PA were able to increase PA on their own when they were given activity trackers. However,
individuals with higher initial PA were more successful at maintaining their PA with the addition
of motivational interviewing and habit education. The results of this study further highlight that
while fitness watches may have some impact on PA, they may need to be used in combination with
behavioral interventions customized to the individual.
In addition to the behavioral benefits of having real-time feedback to help with goal setting and
self-monitoring, fitness watches and activity trackers might be useful tools to help individuals meet
exercise prescriptions set by a medical or exercise professional. Recently, McNeil et al. [13] demonstrated
the ability to increase PA in 45 adult cancer survivors using different prescribed exercise intensities,
including lower-intensity PA (300 min·week−1 at 40–59% of heart-rate reserve) or higher-intensity
PA (150 min·week−1 at 60–80% of heart-rate reserve). These intensity differences were successfully
tracked using Polar 360 activity trackers [13]. Optimal exercise prescription to improve health includes
the FITT-VP principal that outlines exercise guidelines in patients considering frequency, intensity,
time, type, volume, and progression in prescribed exercise programs [2]. Wearable technology that
includes heart-rate tracking can track the intensity of PA in addition to frequency and total time of
exercise sessions [13]. Therefore, a fitness watch can improve motivation and accountability, be part
of a multi-approach program aimed at increasing PA, and can help provide PA intervention-specific
feedback to the participant and prescriber.
3. What are Some Important Considerations and What Research Needs to be Conducted to Help Us
Better Understand the Relationship between Fitness Watch Use and Chronic Disease Management?
We note that while data seems to support that wearable technology positively impacts PA in
chronic diseases, the use of fitness watches and other devices in the context of chronic disease is not
without complexities to consider. We have mentioned the necessity of individualized PA prescription
in those with chronic disease, and that the use of wearable technology may in fact facilitate this.
An individualized approach to managing someone with chronic disease is a necessity, and the same
needs to be considered when we prescribe PA using technology. For example, a prescription to increase
moderate to vigorous PA by 30 min in everyone with type 2 diabetes is not appropriate. There is
a wide range of symptomology within each chronic disease that needs to be considered before we
develop PA interventions, with the assistance of wearable technology or not. For example, in those with
type 2 diabetes, clinical symptoms can include mild to severe peripheral neuropathy, skin weakness,
and open sores, and the consideration of co-morbidities such as chronic kidney disease or hypertension.
Therefore, while wearable technology can be a tool used to increase PA in chronic disease, there are
many challenges associated with chronic disease PA prescription that are not addressed by the use
of technology alone. Population characteristics associated with chronic diseases may also impact
uptake of wearable technology use; for example, older individuals may be less open to (or less likely
to) incorporate technology to increase PA [9]. Therefore, diseases that affect older individuals more
commonly (such as chronic obstructive pulmonary disease) may be more difficult to target with
technology due to differences in technology readiness and literacy. It is important to acknowledge that
increasing PA, even with the use of wearable technology, will likely remain a large challenge.
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As previously discussed, some published research has used fitness watches or similar activity
monitors in combination with other lifestyle interventions to increase PA in those with chronic diseases
or conditions [11–13,15,16]. However, many of these studies include a small sample size and no
control groups. For example, Abrantes et al. piloted an intervention using Fitbit activity monitors to
strategically increase PA in a small group of 15 women with depression, but did not include a control
group in their research design [12]. Despite the small sample sizes and the lack of control groups in
some of these studies [12,15], published pilot research has supported that individuals with chronic
disease are receptive to using fitness watches to track their PA and meet PA goals. Current wearable
technology offers patients many ways to monitor their PA; step count, the number of calories burned
through energy expenditure, the amount of time spent sedentary, or number of minutes of exercise are
all popular ways to monitor PA. However, how each of these measures are calculated (i.e., the equations
used) and/or the accuracy of each of these measures can vary by device. Therefore, future studies
should validate these measurements in a variety of devices, in populations with chronic disease,
to determine which measures most accurately reflect PA participation.
In addition to examining the type of variables used to track activity, future research also should
include high-quality randomized controlled trials that include standard lifestyle interventions with
and without fitness watches to truly determine if the technology is increasing adherence to PA
recommendations. A meta-analysis exploring activity watches in obese populations by de Vries
et al. [11] suggests that behavioral weight-loss interventions employing activity watches (or fitness
watches) increase PA more than usual care [11]. However, this meta-analysis was unable to determine
if a behavioral weight loss-intervention using activity watches to help self-monitor could increase
PA levels more than behavioral interventions without activity watches [11]. Research needs to focus
on examining the use of wearable technology in individual populations with chronic disease, and to
examine the impact on PA as an outcome as well as integration of other health outcomes (such as blood
pressure, quality of life, and longevity).
Not only do we need more research to determine if wearable technology can increase PA and
improve the health of people with chronic diseases, feasibility analyses to determine if wearable
technology (with the goal to increase PA) should be implemented into routine clinical practice are
still required. This research should focus on the economic and operational feasibility of integrating
wearable technology into clinical practice. There are many logistical considerations that would
need to be addressed, for example online portals that need to be available so that members of an
individual’s healthcare team can access the information collected (while still protecting the privacy of
this information). We also need to consider what features of the wearable technology resonate with
people living with chronic disease, and address if more specific technology should be developed for
these populations.
Since the majority of current wearable technologies are not designed to increase PA in patients
with chronic conditions, medical providers, such as doctors and nurses, in combination with exercise
professionals that work with patients with chronic disease, need to understand how goals can be
manipulated using fitness watches. The standard goals of daily PA prescribed to the general healthy
population are not always appropriate for chronic disease (i.e., 150 min of moderate-vigorous PA per
week, and/or 10,000 steps per day); in fact, evidence suggests that clinically meaningful changes in
health may be attained with lower amounts of PA [20]. Nevertheless, these goals are easy to manipulate
through the fitness watch applications, making individualized PA prescription possible. Therefore,
there is a necessary learning opportunity for both individuals with chronic disease who can use
smartwatches to improve PA, as well as the healthcare team that wants to use the fitness watch as a
prescription tool. However, there is still a lack of high-quality research supporting the use of wearable
technology to improve PA and other health outcomes in various chronic diseases.
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4. Conclusions
We know that PA is beneficial at improving a whole range of symptoms associated with chronic
diseases (i.e., poor physical function), at chronic disease prevention (i.e., obesity or cardiovascular
disease), and even treating certain chronic diseases (i.e., type 2 diabetes). Despite this knowledge,
we still struggle to engage individuals with chronic disease in PA participation. While there continues
to be research that examines how PA improves health in chronic disease, and what PA prescription
results in the best improvement in health with the least adverse effects, there is a gap in the published
literature with regards to high-quality intervention delivery. Wearable technology is a potential tool
to facilitate PA prescription and might be an appropriate tool to use in the setting of chronic disease.
High-quality, disease-specific randomized controlled trials that examine many outcomes are still
needed; but, despite the current challenges, we believe that the future of the use of wearable technology
in PA prescription is certainly one that is exciting and encouraging.
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